274 related articles for article (PubMed ID: 11435563)
1. Identification of envelope determinants of feline leukemia virus subgroup B that permit infection and gene transfer to cells expressing human Pit1 or Pit2.
Sugai J; Eiden M; Anderson MM; Van Hoeven N; Meiering CD; Overbaugh J
J Virol; 2001 Aug; 75(15):6841-9. PubMed ID: 11435563
[TBL] [Abstract][Full Text] [Related]
2. Variable regions A and B in the envelope glycoproteins of feline leukemia virus subgroup B and amphotropic murine leukemia virus interact with discrete receptor domains.
Tailor CS; Kabat D
J Virol; 1997 Dec; 71(12):9383-91. PubMed ID: 9371598
[TBL] [Abstract][Full Text] [Related]
3. Three distinct envelope domains, variably present in subgroup B feline leukemia virus recombinants, mediate Pit1 and Pit2 receptor recognition.
Boomer S; Eiden M; Burns CC; Overbaugh J
J Virol; 1997 Nov; 71(11):8116-23. PubMed ID: 9343161
[TBL] [Abstract][Full Text] [Related]
4. Feline Pit2 functions as a receptor for subgroup B feline leukemia viruses.
Anderson MM; Lauring AS; Robertson S; Dirks C; Overbaugh J
J Virol; 2001 Nov; 75(22):10563-72. PubMed ID: 11602698
[TBL] [Abstract][Full Text] [Related]
5. Specificity in receptor usage by T-cell-tropic feline leukemia viruses: implications for the in vivo tropism of immunodeficiency-inducing variants.
Lauring AS; Anderson MM; Overbaugh J
J Virol; 2001 Oct; 75(19):8888-98. PubMed ID: 11533152
[TBL] [Abstract][Full Text] [Related]
6. Fusion-defective gibbon ape leukemia virus vectors can be rescued by homologous but not heterologous soluble envelope proteins.
Farrell KB; Ting YT; Eiden MV
J Virol; 2002 May; 76(9):4267-74. PubMed ID: 11932392
[TBL] [Abstract][Full Text] [Related]
7. A 13-amino-acid Pit1-specific loop 4 sequence confers feline leukemia virus subgroup B receptor function upon Pit2.
Dreyer K; Pedersen FS; Pedersen L
J Virol; 2000 Mar; 74(6):2926-9. PubMed ID: 10684313
[TBL] [Abstract][Full Text] [Related]
8. Genetic and biochemical analyses of receptor and cofactor determinants for T-cell-tropic feline leukemia virus infection.
Lauring AS; Cheng HH; Eiden MV; Overbaugh J
J Virol; 2002 Aug; 76(16):8069-78. PubMed ID: 12134012
[TBL] [Abstract][Full Text] [Related]
9. A comprehensive approach to mapping the interacting surfaces of murine amphotropic and feline subgroup B leukemia viruses with their cell surface receptors.
Tailor CS; Nouri A; Kabat D
J Virol; 2000 Jan; 74(1):237-44. PubMed ID: 10590111
[TBL] [Abstract][Full Text] [Related]
10. Feline leukemia virus envelope sequences that affect T-cell tropism and syncytium formation are not part of known receptor-binding domains.
Gwynn SR; Hankenson FC; Lauring AS; Rohn JL; Overbaugh J
J Virol; 2000 Jul; 74(13):5754-61. PubMed ID: 10846053
[TBL] [Abstract][Full Text] [Related]
11. Reduced Folate Carrier: an Entry Receptor for a Novel Feline Leukemia Virus Variant.
Miyake A; Kawasaki J; Ngo H; Makundi I; Muto Y; Khan AH; Smith DJ; Nishigaki K
J Virol; 2019 Jul; 93(13):. PubMed ID: 30996094
[TBL] [Abstract][Full Text] [Related]
12. Envelope determinants for dual-receptor specificity in feline leukemia virus subgroup A and T variants.
Cheng HH; Anderson MM; Hankenson FC; Johnston L; Kotwaliwale CV; Overbaugh J
J Virol; 2006 Feb; 80(4):1619-28. PubMed ID: 16439518
[TBL] [Abstract][Full Text] [Related]
13. Cellular and species resistance to murine amphotropic, gibbon ape, and feline subgroup C leukemia viruses is strongly influenced by receptor expression levels and by receptor masking mechanisms.
Tailor CS; Nouri A; Kabat D
J Virol; 2000 Oct; 74(20):9797-801. PubMed ID: 11000257
[TBL] [Abstract][Full Text] [Related]
14. Feline leukemia virus infection requires a post-receptor binding envelope-dependent cellular component.
Hussain N; Thickett KR; Na H; Leung C; Tailor CS
J Virol; 2011 Dec; 85(23):12529-36. PubMed ID: 21917946
[TBL] [Abstract][Full Text] [Related]
15. Host cell range of T-lymphotropic feline leukemia virus in vitro.
Shojima T; Nakata R; Miyazawa T
Biochem Biophys Res Commun; 2006 Jul; 345(4):1466-70. PubMed ID: 16730653
[TBL] [Abstract][Full Text] [Related]
16. Identification of an extracellular domain within the human PiT2 receptor that is required for amphotropic murine leukemia virus binding.
Feldman SA; Farrell KB; Murthy RK; Russ JL; Eiden MV
J Virol; 2004 Jan; 78(2):595-602. PubMed ID: 14694091
[TBL] [Abstract][Full Text] [Related]
17. The receptor binding site of feline leukemia virus surface glycoprotein is distinct from the site involved in virus neutralization.
Ramsey IK; Spibey N; Jarrett O
J Virol; 1998 Apr; 72(4):3268-77. PubMed ID: 9525654
[TBL] [Abstract][Full Text] [Related]
18. Reassessing the role of region A in Pit1-mediated viral entry.
Farrell KB; Russ JL; Murthy RK; Eiden MV
J Virol; 2002 Aug; 76(15):7683-93. PubMed ID: 12097582
[TBL] [Abstract][Full Text] [Related]
19. Feline leukemia virus T entry is dependent on both expression levels and specific interactions between cofactor and receptor.
Cheng HH; Anderson MM; Overbaugh J
Virology; 2007 Mar; 359(1):170-8. PubMed ID: 17046042
[TBL] [Abstract][Full Text] [Related]
20. Improved gene transfer into human lymphocytes using retroviruses with the gibbon ape leukemia virus envelope.
Lam JS; Reeves ME; Cowherd R; Rosenberg SA; Hwu P
Hum Gene Ther; 1996 Aug; 7(12):1415-22. PubMed ID: 8844200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]